Form 4 for BBOT BridgeBio Oncology Therapeutics, Inc.
Accepted 2026-07-06 18:00:03 ET · period of report 2026-07-01 · accession 0001193125-26-296501 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 18:00 | 2026-07-01 | BBOT | Beltran Pedro | Pres, CEO, Dir | F - Tax | $7.80 | -1,047 | 44.6K | -2% | -$8,167 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-01 | F | D | 1,047 | $7.80 | 44,576 | D | — | — | (F1) Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. |